The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Usha Lee McFarling ...

The FDA and other HHS agencies of interest to the pharma sphere have seen President Donald Trump’s first 100 days as he ...

Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.” ...

Pfizer said today it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research ...

Kennedy has focused his healthcare crusade on his contention that American healthcare prioritizes treating chronic illnesses ...